PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
+17.12%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.44B
AUM Growth
+$3.44B
Cap. Flow
-$426M
Cap. Flow %
-12.37%
Top 10 Hldgs %
43.73%
Holding
111
New
9
Increased
21
Reduced
33
Closed
19
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TERN icon
101
Terns Pharmaceuticals
TERN
$651M
-1,350,000
Closed -$16M
XBI icon
102
SPDR S&P Biotech ETF
XBI
$5.29B
0
MORF
103
DELISTED
Morphic Holding, Inc. Common Stock
MORF
-256,737
Closed -$9.66M
RAIN
104
DELISTED
Rain Oncology Inc. Common Stock
RAIN
-1,648,215
Closed -$14.4M
PNT
105
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
0
CELL
106
DELISTED
PhenomeX Inc. Common Stock
CELL
-2,506,442
Closed -$2.91M
BLU
107
DELISTED
BELLUS Health Inc.
BLU
-4,952,538
Closed -$35.7M
RXDX
108
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-1,272,694
Closed -$137M
PEAR
109
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
-900,548
Closed -$230K
ATNX
110
DELISTED
Athenex, Inc. Common Stock
ATNX
-776,623
Closed -$1.03M
BLPH
111
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
-930,000
Closed -$7.34M